(Q34086056)

30 July 2017

1 reference

title

Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects (English)

1 reference

arteriosclerotic heart disease

30 July 2017

1 reference

Markham A

1

1 reference

30 July 2017

Plosker GL

series ordinal

2

1 reference

30 July 2017

Goa KL

series ordinal

3

1 reference

30 July 2017

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

60

1 reference

30 July 2017

4

1 reference

30 July 2017

955-974

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200060040-00007

30 July 2017

0 references

cites work

Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial

1 reference

12 December 2020

Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients

1 reference

12 December 2020

Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.

1 reference

12 December 2020

Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT

1 reference

12 December 2020

Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina

1 reference

12 December 2020

Antiischemic effects of nicorandil during coronary angioplasty in humans

1 reference

12 December 2020

Mitochondria: a new target for K channel openers?

1 reference

12 December 2020

Pharmacology of the potassium channel openers.

1 reference

12 December 2020

Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction

1 reference

12 December 2020

Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas

1 reference

12 December 2020

Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features

1 reference

12 December 2020

Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group

1 reference

12 December 2020

Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy

1 reference

12 December 2020

A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris

1 reference

12 December 2020

Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs

1 reference

12 December 2020

Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris

1 reference

12 December 2020

Activation of adenosine triphosphate-regulated potassium channels: mediation of cellular and organ protection

1 reference

12 December 2020

KATP channel activation mediates nicorandil-induced relaxation of nitrate-tolerant coronary arteries

1 reference

12 December 2020

Hemodynamic action of nicorandil in chronic congestive heart failure.

1 reference

12 December 2020

Acute hemodynamic effects of single-dose nicorandil in coronary artery disease

1 reference

12 December 2020

Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs

1 reference

12 December 2020

Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease.

1 reference

12 December 2020

Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.

1 reference

12 December 2020

Pharmacokinetic profile of nicorandil in humans: an overview

1 reference

12 December 2020

Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.

1 reference

12 December 2020

Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction

1 reference

12 December 2020

Chronic buccal ulceration induced by nicorandil

1 reference

12 December 2020

Investigation and management of stable angina: revised guidelines 1998. Joint Working Party of the British Cardiac Society and Royal College of Physicians of London.

1 reference

12 December 2020

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

12 December 2020

ATP dependent K+ channel: a novel therapeutic target in unstable angina

1 reference

12 December 2020

Nicorandil-induced severe oral ulceration: a newly recognized drug reaction

1 reference

12 December 2020

Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure

1 reference

12 December 2020

Reduction of size of myocardial infarction with nicorandil, a new antianginal drug, after coronary artery occlusion in dogs

1 reference

12 December 2020

Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris

1 reference

12 December 2020

Effect of nitroglycerin and nicorandil on regional poststenotic quantitative coronary blood flow in coronary artery disease: a combined digital quantitative angiographic and intracoronary doppler study

1 reference

12 December 2020

Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits

1 reference

12 December 2020

Safety profile of nicorandil--prescription-event monitoring (PEM) study

1 reference

12 December 2020

Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.

1 reference

12 December 2020

The role of ATP-sensitive potassium channels in the mechanism of ischemic preconditioning

1 reference

12 December 2020

Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study

1 reference

12 December 2020

Selected issues from an overview on nicorandil: tolerance, duration of action, and long-term efficacy

1 reference

12 December 2020

Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris

1 reference

12 December 2020

Effects of Nicorandil and Nifedipine on Protection of Ischemic Myocardium

1 reference

12 December 2020

Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart

1 reference

12 December 2020

Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction

1 reference

12 December 2020

Nicorandil safety in the long-term treatment of coronary heart disease

1 reference

12 December 2020

Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction

1 reference

12 December 2020

Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study

1 reference

12 December 2020

Acute Hemodynamic Effects of Nicorandil in Coronary Artery Disease

1 reference

12 December 2020

Safety profile of an anti-anginal agent with potassium channel opening activity: an overview

1 reference

12 December 2020

Chronic effects of nicorandil on exercise tolerance in patients with stable effort angina pectoris

1 reference

12 December 2020

Ischaemic preconditioning: is it clinically relevant?

1 reference

12 December 2020

A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris

1 reference

12 December 2020

Giant oral aphthous ulcers induced by nicorandil

1 reference

12 December 2020

Comparison of tolerance to intravenous nitroglycerin during nicorandil and intermittent nitroglycerin patch in healthy volunteers.

1 reference

12 December 2020

The pharmacokinetics and haemodynamic effects of continuous nicorandil infusion in healthy volunteers

1 reference

12 December 2020

Effect of nicorandil on post-ischaemic contractile dysfunction in the heart: roles of its ATP-sensitive K+ channel opening property and nitrate property

1 reference

12 December 2020

A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina

1 reference

12 December 2020

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

12 December 2020

Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo.

1 reference

12 December 2020

Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure

1 reference

12 December 2020

Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels.

1 reference

12 December 2020

Pharmacokinetics of nicorandil in patients with normal and impaired renal function

1 reference

12 December 2020

10.2165/00003495-200060040-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference